EVALUATION OF SIALOGOGIC ACTION OF CYCLOCYTIDINE (NSC-145668) AND ANHYDRO-ARA-5-FLUOROCYTIDINE (NSC-166641).SCHNEYER CA; GALBRAITH WM.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 5; PP. 1019; BIBL. 4 REF.Article

INFLUENCE OF ROUTE OF ADMINISTRATION OF ANTILEUKEMIC ACTIVITY OF CYCLOCYTIDINE = INFLUENCE DE LA VOIE D'ADMINISTRATION SUR L'ACTION ANTILEUCEMIQUE DE LA CYCLOCYTIDINEHOSHI A; KANZAWA F; KURETANI K et al.1972; GANN; JAP.; DA. 1972; VOL. 63; NO 2; PP. 279-280; BIBL. 3 REF.Serial Issue

EFFECT OF 2,2-O-CYCLOCYTIDINE ON TRANSPLANTED LYMPHOCYTIC SARCOMA AND RETICULUM CELL SARCOMA IN MICE = EFFET DE LA 2,2-O-CYCLOCYTIDINE SUR LES SARCOMES LYMPHOCYTAIRES TRANSPLANTES ET SUR LE SARCOME RETICULOCELLULAIRE CHEZ LES SOURISNAKAHARA W; TOKUZEN R.1972; GANN; JAP.; DA. 1972; VOL. 63; NO 3; PP. 379-381; BIBL. 6REF.Serial Issue

COMPARATIVE ULTRASTRUCTURE OF SUBMAXILLARY SALIVARY GLANDS FROM MICE TREATED WITH CYTOSINE ARABINOSIDE, CYCLOCYTIDINE, AND ANHYDRO-ARA-5-FLUOROCYTIDINE.LISS RH; CHAREST MC; MEAD JAR et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 7; PP. 881-888; BIBL. 31 REF.Article

SPECIFIC INHIBITION OF DNA SYNTHESIS BY CYCLOCYTIDINEHOSHI A; YOSHIDA M; KANZAWA F et al.1972; CHEM. PHARM. BULL.; JAP.; DA. 1972; VOL. 20; NO 10; PP. 2286-2287; BIBL. 3REF.Serial Issue

CLINICAL PHARMACOLOGY OF O²,2PRIME -CYCLOCYTIDINEHO DHW; RODRIGUEZ V; TI LI LOO et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 17; NO 1; PP. 66-72; BIBL. 23REF.Article

DISTRIBUTION AND EXCRETION OF ³H-CYCLOCYTIDINE IN RHESUS MONKEYS.NISHIMURA M; HAMADA F; SUGIHARA T et al.1975; JAP. J. VETER. SCI.; JAP.; DA. 1975; VOL. 37; NO 3; PP. 293-300; BIBL. 13 REF.Article

UNEXPECTED BETA ADRENERGIC EFFECTS OF THE ANTITUMOR AGENT, CYCLOCYTIDINE, ON RAT SALIVARY GLANDS = EFFETS BETA -ADRENERGIQUES INATTENDUS DE L'AGENT ANTITUMORAL, CYCLOCYTIDINE, SUR LES GLANDES SALIVAIRES DU RATSCHNEYER CA; GALBRAITH WM; MELLETT LB et al.1975; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1975; VOL. 148; NO 4; PP. 1206-1211; BIBL. 16 REF.Article

DISTRIBUTION OF CYCLOCYTIDINE IN TISSUES.HOSHI A; IIGO M; KURETANI K et al.1975; CHEM. PHARM. BULL.; JAP.; DA. 1975; VOL. 23; NO 4; PP. 725-728; BIBL. 8 REF.Article

METABOLITES OF 5-³H-CYCLOCYTIDINE IN MONKEYS GIVEN SINGLE INTRAVENOUS INJECTIONHAMADA F; SUGIHARA T; TSUYAMA S et al.1975; CHEM. PHARM. BULL.; JAP.; DA. 1975; VOL. 23; NO 3; PP. 586-591; BIBL. 14 REF.Article

DIFFERENTIAL ANALYSIS OF CYCLOCYTIDINE, 1-BETA -D-ARABINOFURANOSYLCYTOSINE, AND 1-BETA -D-ARABINOFURANOSYLURACIL BY ULTRAVIOLET SPECTOPHOTOMETRY = ANALYSE DIFFERENTIELLE DE LA CYCLOCYTIDINE, DE LA 1-BETA -D-ARABINOFURANOSYLCYTOSINE ET DU 1-BETA -D-ARABINOFURANOSYLURACIL PAR LA SPECTROPHOTOMETRIE UVFURNER RL; GASTON RW; STROBEL JD et al.1974; J. NATION. CANCER INST.; U.S.A.; DA. 1974; VOL. 52; NO 5; PP. 1521-1528; BIBL. 8REF.Article

Hybrid hexanucleotide duplex containing cyclonucleotides and deoxynucleotides: the d(TA) segment can adopt a high anti left-handed double-helical structureUESUGI, S; LEE, B. L; IKEHARA, M et al.Biochemistry (Easton). 1988, Vol 27, Num 2, pp 521-525, issn 0006-2960Article

METABOLISM OF CYCLOCYTIDINE AND ARACYTIDINE IN MICE.HOSHI A; YOSHIDA M; KURETANI K et al.1975; CHEM. PHARM. BULL.; JAP.; DA. 1975; VOL. 23; NO 8; PP. 1814-1818; BIBL. 13 REF.Article

TRAITEMENT DE LA KERATITE HERPETIQUE PROFONDE EXPERIMENTALE PAR LA CYCLOCYTIDINE ET L'ARABINOSIDE D'ADENINEKAJIWARA K; TERANISHI H; ISHIZUKI M et al.1977; ACTA SOC. OPHTHALMOL. JAP.; JAP.; DA. 1977; VOL. 81; NO 9; PP. 1274-1278; ABS. ANGL.; BIBL. 15 REF.Article

COMPARATIVE STUDIES OF CYCLOCYTIDINE (NSC-145668) AND CYTOSINE ARABINOSIDE (NSC-63878) IN MICE.LISS RH; NEIL GL.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 1; PP. 501-513; BIBL. 19 REF.Article

INHIBITION OF CYCLOCYTIDINE-INDUCED ENLARGEMENT OF PAROTID AND HEART BY PROPRANOLOL OR SYMPATHECTOMY. = INHIBITION PAR LE PROPRANOLOL OU LA SYMPATHECTOMIE DE L'AUGMENTATION DE VOLUME DE LA PAROTIDE ET DU COEUR PROVOQUEE PAR LA CYCLOCYTIDINESCHNEYER CA; GALBRAITH WM.1975; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1975; VOL. 150; NO 2; PP. 394-400; BIBL. 13 REF.Article

DISTRIBUTION AND EXCRETION OF ¹⁴C-CYCLOCYTIDINE IN EXPERIMENTAL ANIMALS.EL DAREER S; WHITE VM; TILLERY K et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 5; PP. 805-814; BIBL. 39 REF.Article

EFFECT AND TOXICITY OF COMBINATION TREATMENT INCLUDING CYCLOCYTIDINE OR CYTOSINE ARABINOSIDE IN "L1210 AND SARCOMA-180 SYSTEMSHOSHI A; KANZAWA F; IIGO M et al.1975; GANN; JAP.; DA. 1975; VOL. 66; NO 5; PP. 539-546; BIBL. 12 REF.Article

SOME CARDIOVASCULAR EFFECTS OF CYCLOCYTIDINE.HERMAN EH; CHADWICK DP.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 11; PP. 1663-1666; BIBL. 9 REF.Article

A RAPID STABILITY-INDICATING HPLC ASSAY FOR THE ARABINOSYLCYTOSINE PRODRUG, CYCLOCYTIDINETUNCEL M; NOTARI RE; MALSPEIS L et al.1981; J. LIQ. CHROMATOGR.; ISSN 0148-3919; USA; DA. 1981; VOL. 4; NO 5; PP. 887-896; BIBL. 4 REF.Article

EVALUATION OF CYCLOCYTIDINE IN CHILDREN WITH ADVANCED ACUTE LEUKEMIA AND SOLID TUMORSFINKLESTEIN JZ; HIGGINS G; KRIVIT W et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 8; PP. 1331-1333; BIBL. 11 REF.Article

MATHEMATICAL MODEL FOR CYCLOCYTIDINE PHARMACOKINETICS.HIMMELSTEIN KJ; GROSS JF.1977; J. PHARM. SCI.; U.S.A.; DA. 1977; VOL. 66; NO 10; PP. 1441-1444; BIBL. 20 REF.Article

COMBINED EFFECT OF CYCLOCYTIDINE AND LENTINAN ON SPONTANEOUS MAMMARY TUMORS IN MICE.TOKUZEN R; OKABE M; NAKAHARA W et al.1976; GANN; JAP.; DA. 1976; VOL. 67; NO 2; PP. 327-329; BIBL. 8 REF.Article

TYRAMINE-LIKE EFFECT OF CYCLOCYTIDINE (2,2'-ANHYDRO-1-BETA-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE), AN ANTINEOPLASTIC AGENT.OGURO K; HASHIMOTO K.1978; TOHOKU J. EXPER. MED.; JPN; DA. 1978; VOL. 124; NO 1; PP. 83-90; BIBL. 1 P. 1/2Article

PHASE I-II EVALUATION OF CYCLOCYTIDINE.BURGESS MA; BODEY GP; MINOW RA et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 3; PP. 437-443; BIBL. 25 REF.Article